Nicole Crepaz1, Tian Tang2, Gary Marks1, Michael J Mugavero3, Lorena Espinoza1, H Irene Hall1. 1. Division of HIV/AIDS Prevention, US Centers for Disease Control and Prevention. 2. ICF International, Atlanta, Georgia. 3. Department of Medicine, Division of Infectious Diseases, University of Alabama, Birmingham.
Abstract
BACKGROUND: We examined durable viral suppression, cumulative viral load (VL) burden, and transmission risk potential among human immunodeficiency virus (HIV)-diagnosed persons in care. METHODS: Using data from the National HIV Surveillance System from 17 jurisdictions with complete reporting of VL test results, we determined the percentage of persons in HIV care who achieved durable viral suppression (all VL results <200 copies/mL) and examined viremia copy-years and time spent above VL levels that increase the risk of HIV transmission during 2012-2013. RESULTS: Of 265 264 persons in HIV care in 2011, 238 641 had at least 2 VLs in 2012-2013. The median number of VLs per individual during the 2-year period was 5. Approximately 62% had durable viral suppression. The remaining 38% had high VL burden (geometric mean of viremia copy-years, 7261) and spent an average of 438 days, 316 days, and 215 days (60%, 43.2%, and 29.5% of the 2-year period) above 200, 1500, and 10 000 copies/mL. Women, blacks/African Americans, Hispanics/Latinos, persons with HIV infection attributed to transmission other than male-to-male sexual contact, younger age groups, and persons with gaps in care had higher viral burden and transmission risk potential. CONCLUSIONS: Two-thirds of persons in HIV care had durable viral suppression during a 2-year period. One-third had high VL burden and spent substantial time above VL levels with increased risk of onward transmission. More intervention efforts are needed to improve retention in care and medication adherence so that more persons in HIV care achieve durable viral suppression. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: We examined durable viral suppression, cumulative viral load (VL) burden, and transmission risk potential among human immunodeficiency virus (HIV)-diagnosed persons in care. METHODS: Using data from the National HIV Surveillance System from 17 jurisdictions with complete reporting of VL test results, we determined the percentage of persons in HIV care who achieved durable viral suppression (all VL results <200 copies/mL) and examined viremia copy-years and time spent above VL levels that increase the risk of HIV transmission during 2012-2013. RESULTS: Of 265 264 persons in HIV care in 2011, 238 641 had at least 2 VLs in 2012-2013. The median number of VLs per individual during the 2-year period was 5. Approximately 62% had durable viral suppression. The remaining 38% had high VL burden (geometric mean of viremia copy-years, 7261) and spent an average of 438 days, 316 days, and 215 days (60%, 43.2%, and 29.5% of the 2-year period) above 200, 1500, and 10 000 copies/mL. Women, blacks/African Americans, Hispanics/Latinos, persons with HIV infection attributed to transmission other than male-to-male sexual contact, younger age groups, and persons with gaps in care had higher viral burden and transmission risk potential. CONCLUSIONS: Two-thirds of persons in HIV care had durable viral suppression during a 2-year period. One-third had high VL burden and spent substantial time above VL levels with increased risk of onward transmission. More intervention efforts are needed to improve retention in care and medication adherence so that more persons in HIV care achieve durable viral suppression. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: Gary Marks; Unnati Patel; Michael J Stirratt; Michael J Mugavero; William C Mathews; Thomas P Giordano; Nicole Crepaz; Lytt I Gardner; Cynthia Grossman; Jessica Davila; Meg Sullivan; Charles E Rose; Christine OʼDaniels; Allan Rodriguez; Andrew J Wawrzyniak; Matthew R Golden; Shireesha Dhanireddy; Jacqueline Ellison; Mari-Lynn Drainoni; Lisa R Metsch; Edward R Cachay Journal: J Acquir Immune Defic Syndr Date: 2016-10-01 Impact factor: 3.731
Authors: Nicole Crepaz; Malu V Tungol-Ashmon; Darrel H Higa; Waverly Vosburgh; Mary M Mullins; Terrika Barham; Adebukola Adegbite; Julia B DeLuca; Theresa A Sipe; Christina M White; Brittney N Baack; Cynthia M Lyles Journal: AIDS Date: 2014-03-13 Impact factor: 4.177
Authors: T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray Journal: N Engl J Med Date: 2000-03-30 Impact factor: 91.245
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Michael J Mugavero; Sonia Napravnik; Stephen R Cole; Joseph J Eron; Bryan Lau; Heidi M Crane; Mari M Kitahata; James H Willig; Richard D Moore; Steven G Deeks; Michael S Saag Journal: Clin Infect Dis Date: 2011-09-02 Impact factor: 9.079
Authors: Alexander Zoufaly; Hans-Jürgen Stellbrink; Matthias An der Heiden; Christian Kollan; Christian Hoffmann; Jan van Lunzen; Osamah Hamouda Journal: J Infect Dis Date: 2009-07-01 Impact factor: 5.226
Authors: Keri N Althoff; Kate Buchacz; H Irene Hall; Jinbing Zhang; David B Hanna; Peter Rebeiro; Stephen J Gange; Richard D Moore; Mari M Kitahata; Kelly A Gebo; Jeffrey Martin; Amy C Justice; Michael A Horberg; Robert S Hogg; Timothy R Sterling; Angela Cescon; Marina B Klein; Jennifer E Thorne; Heidi M Crane; Michael J Mugavero; Sonia Napravnik; Gregory D Kirk; Lisa P Jacobson; John T Brooks Journal: Ann Intern Med Date: 2012-09-04 Impact factor: 25.391
Authors: Heather Bradley; H Irene Hall; Richard J Wolitski; Michelle M Van Handel; Amy E Stone; Michael LaFlam; Jacek Skarbinski; Darrel H Higa; Joseph Prejean; Emma L Frazier; Roshni Patel; Ping Huang; Qian An; Ruiguang Song; Tian Tang; Linda A Valleroy Journal: MMWR Morb Mortal Wkly Rep Date: 2014-11-28 Impact factor: 17.586
Authors: Jeanne M Marrazzo; Carlos del Rio; David R Holtgrave; Myron S Cohen; Seth C Kalichman; Kenneth H Mayer; Julio S G Montaner; Darrell P Wheeler; Robert M Grant; Beatriz Grinsztejn; N Kumarasamy; Steven Shoptaw; Rochelle P Walensky; Francois Dabis; Jeremy Sugarman; Constance A Benson Journal: JAMA Date: 2014 Jul 23-30 Impact factor: 56.272
Authors: Kevin A Jefferson; Laura S Kersanske; Mary E Wolfe; Sarah L Braunstein; Regine Haardörfer; Don C Des Jarlais; Aimee N C Campbell; Hannah Lf Cooper Journal: AIDS Care Date: 2018-11-26
Authors: Gary Marks; Christine O'Daniels; Cynthia Grossman; Nicole Crepaz; Charles E Rose; Unnati Patel; Michael J Stirratt; Lytt I Gardner; Edward R Cachay; William C Mathews; Mari-Lynn Drainoni; Meg Sullivan; Lucy Bradley-Springer; Marla Corwin; Christopher Gordon; Allan Rodriguez; Shireesha Dhanireddy; Thomas P Giordano Journal: AIDS Care Date: 2018-08-16
Authors: Forrest Toegel; August F Holtyn; Sarah Pollock; Andrew M Rodewald; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman Journal: HIV Res Clin Pract Date: 2020-03-05
Authors: Shrinidhi Subramaniam; Carol-Ann Getty; August F Holtyn; Andrew Rodewald; Brian Katz; Brantley P Jarvis; Jeannie-Marie S Leoutsakos; Michael Fingerhood; Kenneth Silverman Journal: AIDS Behav Date: 2019-11
Authors: Robert H Paul; Kyu S Cho; Patrick Luckett; Jeremy F Strain; Andrew C Belden; Jacob D Bolzenius; Jaimie Navid; Paola M Garcia-Egan; Sarah A Cooley; Julie K Wisch; Anna H Boerwinkle; Dimitre Tomov; Abel Obosi; Julie A Mannarino; Beau M Ances Journal: J Acquir Immune Defic Syndr Date: 2020-08-01 Impact factor: 3.731
Authors: Irene S Yoon; Martin J Downing; Richard Teran; Mary Ann Chiasson; Steven T Houang; Jeffrey T Parsons; Sabina Hirshfield Journal: AIDS Care Date: 2017-12-19
Authors: Matthew E Levy; Anne K Monroe; Michael A Horberg; Debra A Benator; Sherry Molock; Rupali K Doshi; Lindsey Powers Happ; Amanda D Castel Journal: J Acquir Immune Defic Syndr Date: 2019-11-01 Impact factor: 3.731
Authors: John A Sauceda; Ronald A Brooks; Jessica Xavier; Andres Maiorana; Lisa Georgetti Gomez; Sophia Zamudio-Haas; Carlos E Rodriguez-Diaz; Adan Cajina; Janet Myers Journal: J Immigr Minor Health Date: 2019-04